Similar Search Results

Consequences of the TRIPS-Agreement for the provision of pharmaceuticals in developing countries

Oppermann, Julia - 2008

Arzneimittel zur Behandlung dieser Krankheit. Zum anderen wurde auch der Mangel wirksamer Medikamente gegen vernachlässigte … Immatrialgüterrechte wesentliche Vorraussetzung für die konstante Entwicklung innovativer Arzneimittel seien. Kritiker des TRIPS … Arzneimittel gegen vernachlässigte Krankheiten bis zum 30.06.2008 überprüft. Unter Berücksichtigung des kurzfristigen …

Persistent link: https://www.econbiz.de/10009475357

Modeling Agricultural Innovation in a Rapidly Developing Country: The Case of Chinese Pesticide Industry

Shi, Guanming; Pray, Carl - 2011

innovation or imitation by developing a conceptual model and then empirically testing it using pesticide innovation data from a …

Persistent link: https://www.econbiz.de/10009444336

Optimal Management of Renewable Resources: A Dynamic Model of Surface Water Contamination From Pesticide Use in Rice Production in the Mekong Delta, Vietnam

Dang, Phuong M. - 2002

function, and the parameter of pesticide discharge. The total loss of fish culture (total external cost in the year 2001) due … to pesticide use is about 9 billion $US. Two cases of linear and nonlinear forms are simulated with scenarios of initial …

Persistent link: https://www.econbiz.de/10009451201

Auswirkungen von Medikamentengenehmigungen auf die Bewertung von Biotech- und Pharmaunternehmen: Eine Ereignisstudie. Eine empirische Untersuchung

Sturm, Andreas - 2006

Die Arbeit untersucht den Einfluss der Genehmigung von Medikamenten durch die amerikanische Zulassungsbehörde FDA (Food and Drug Administration) auf den Aktienkurs der Antrag stellenden Aktiengesellschaft. Dabei werden Genehmigungen von wichtigen pharmazeutischen und biopharmazeutischen...

Persistent link: https://www.econbiz.de/10009450191

Change agents and the evolution of the United States pharmaceutical industry, 1920--1960

Lee, Jeho - 1996

This dissertation examines the evolution of the market and the firms in the context of an emerging innovative race in the U.S. pharmaceutical industry. The history shows the existence of two distinct industry regimes. Before 1940, the industry can best be characterized as a competitive regime in...

Persistent link: https://www.econbiz.de/10009439017

Canada-India firm collaboration in health biotechnology

Ray, Monali; Thorsteinsdóttir, Halla - 2008

Strategic alliances are of critical importance to firms working in the health biotechnology2 field. Collaborations can provide firms with significant competitive advantages, shape their economic performance and help minimize risks in development activities (Hagedoorn, 1993). Alliances in the...

Persistent link: https://www.econbiz.de/10009475749

Human resource management and learning based on in-house R&D in a developing country context

Santiago, Fernando; Alcorta, Ludovico - 2009

This paper investigates the influence of human resource management practices on the likelihood that a firm performs in-house R&D. The latter is broadly interpreted as learning---a mechanism promoting absorptive capacity and supporting technology capability-building in latecomer firms. The use of...

Persistent link: https://www.econbiz.de/10009476008

Intellectual Property Rights Regime and Creation of Innovation Based Enterprises in India

Basant, Rakesh - 2006

pharmaceuticals- biotechnologysectors. It is built on the premise that ceteris paribus participation of Indian firms in IPcreation and …

Persistent link: https://www.econbiz.de/10009476130

Farmacijos pramonės etinės problemos

Broga, Mindaugas - 2010

Šiame darbe stengiamasi išanalizuoti farmacijos pramonės etines problemas ir pateikti galimus šių problemų sprendimo būdus bei ateities perspektyvas. Farmacijos produktų specifika nulemia farmacijos kompanijų moralinių ir socialinių pareigų visumą ir įpareigoja kompanijas ne tik...

Persistent link: https://www.econbiz.de/10009479276

Empirical Essays in Health Economics

Garthwaite, Craig Loren - 2009

Chapter 1: The Economic Effects of Medical Innovations: Vioxx and Labor SupplyDespite dramatic improvements in medical technology over time, comparatively little attention has been paid to the effect of these innovations on economic outcomes. This study uses seven overlapping panels of the...

Persistent link: https://www.econbiz.de/10009450754